Highlights Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Real-time Estimate Cboe BZX Other stock markets 15:08:59 10/09/2024 BST			5-day change	1st Jan Change
16.14 ^USD	-1.01%		-0.66%	-13.82%

09-04	Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 04:50 PM
08-27	Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital	08-27	MT
Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q2 Revenue $39M	08-08	MT
Arcus Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	08-08	CI
Sagimet Biosciences Inc. Announces Appointment of Board of Directors	08-01	CI
Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan	07-09	MT
Sector Update: Health Care Stocks Advance in Afternoon Trading	07-05	MT
ITeos, Arcus Shares Drop After Genentech's Lung Cancer Study Misses Endpoints	07-05	MT
Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer	06-10	MT
Arcus Biosciences, Inc. Completes Patient Enrollment in Phase 3 Trial Evaluating A Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers	06-10	CI
Gilead Sciences, Arcus Biosciences's Colorectal Cancer Combination Therapy Shows Promise	06-03	MT
Gilead and Arcus Announces Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-Line Metastatic Colorectal Cancer	06-02	CI
Gilead Sciences, Inc. and Arcus Biosciences, Inc. Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as A First-Line Treatment for Upper GI Cancers	06-01	CI
Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M	05-08	MT
Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M	05-08	MT
Arcus Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q4 Revenue $31M	02-21	MT
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-21	CI
Gilead and Arcus Announce Amended Collaboration Agreement	01-31	CI
Global markets live: WPP UPS GM, Super Micro Computer, Microsoft...	01-30
North American Morning Briefing : Microsoft Kicks Off Big Tech Bonanza	01-30	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Highlights

Filters